Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osteopontin inhibits nucleation of calcium oxalate crystals.

Literature DB >> 7785921

Osteopontin inhibits nucleation of calcium oxalate crystals.

E M Worcester¹, A M Beshensky.

Abstract

Entities: Chemical Gene

Mesh：

Substances：

Year: 1995 PMID： 7785921 DOI： 10.1111/j.1749-6632.1995.tb44661.x

Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. Kinetics of calcium oxalate crystal formation in urine.

Authors: Norbert Laube; Florian Klein; Falk Bernsmann
Journal: Urolithiasis Date: 2016-06-21 Impact factor: 3.436

2. Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats.

Authors: Jun Mi; Jianmin Duan; Jun Zhang; Jianzhong Lu; Hanzhang Wang; Zhiping Wang
Journal: Urol Res Date: 2011-08-06

3. Mechanisms of Stone Formation.

Authors: Vishal N Ratkalkar; Jack G Kleinman
Journal: Clin Rev Bone Miner Metab Date: 2011-12

4. Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.

Authors: Maurizio Bruschi; Simona Granata; Laura Santucci; Giovanni Candiano; Antonia Fabris; Nadia Antonucci; Andrea Petretto; Martina Bartolucci; Genny Del Zotto; Francesca Antonini; Gian Marco Ghiggeri; Antonio Lupo; Giovanni Gambaro; Gianluigi Zaza
Journal: Clin J Am Soc Nephrol Date: 2019-04-24 Impact factor: 8.237

10. Development of a two-stage in vitro model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 1-biomimetic Randall's plaque using decellularized porcine kidneys.

Authors: Archana C Lovett; Saeed R Khan; Laurie B Gower
Journal: Urolithiasis Date: 2018-05-18 Impact factor: 3.436

Osteopontin inhibits nucleation of calcium oxalate crystals.

1. Kinetics of calcium oxalate crystal formation in urine.

2. Evaluation of antiurolithic effect and the possible mechanisms of Desmodium styracifolium and Pyrrosiae petiolosa in rats.

3. Mechanisms of Stone Formation.

4. Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease.

5. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.

6. Relative deficiency of acidic isoforms of osteopontin from stone former urine.

Review 7. The role of osteopontin in kidney diseases.

Review 8. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.

9. Molecular modulation of calcium oxalate crystallization by osteopontin and citrate.

10. Development of a two-stage in vitro model system to investigate the mineralization mechanisms involved in idiopathic stone formation: stage 1-biomimetic Randall's plaque using decellularized porcine kidneys.